D.E. Shaw & Co’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.1M | Buy |
1,601,808
+318,018
| +25% | +$4.58M | 0.02% | 652 |
|
|
2025
Q1 | $8.86M | Buy |
1,283,790
+272,500
| +27% | +$1.88M | 0.01% | 1064 |
|
|
2024
Q4 | $5.36M | Buy |
1,011,290
+957,665
| +1,786% | +$5.08M | ﹤0.01% | 1264 |
|
|
2024
Q3 | $196K | Buy |
+53,625
| New | +$196K | ﹤0.01% | 2826 |
|
|
2023
Q3 | – | Sell |
-37,694
| Closed | -$59.2K | – | 3299 |
|
|
2023
Q2 | $59.2K | Sell |
37,694
-58,319
| -61% | -$91.6K | ﹤0.01% | 2730 |
|
|
2023
Q1 | $147K | Sell |
96,013
-60,433
| -39% | -$92.5K | ﹤0.01% | 2851 |
|
|
2022
Q4 | $263K | Buy |
156,446
+63,914
| +69% | +$107K | ﹤0.01% | 2947 |
|
|
2022
Q3 | $114K | Buy |
92,532
+25,208
| +37% | +$31.1K | ﹤0.01% | 3307 |
|
|
2022
Q2 | $112K | Sell |
67,324
-18,171
| -21% | -$30.2K | ﹤0.01% | 3533 |
|
|
2022
Q1 | $210K | Buy |
85,495
+23,453
| +38% | +$57.6K | ﹤0.01% | 3604 |
|
|
2021
Q4 | $232K | Buy |
62,042
+15,226
| +33% | +$56.9K | ﹤0.01% | 3425 |
|
|
2021
Q3 | $294K | Sell |
46,816
-41,336
| -47% | -$260K | ﹤0.01% | 3071 |
|
|
2021
Q2 | $869K | Buy |
+88,152
| New | +$869K | ﹤0.01% | 2592 |
|